The positive rates of α-SMA expression in the HGIEN, CIS and SCC groups were statistically significant when compared with that of the normal group; however, no significant difference in α-SMA expression rates was identified between the LGIEN and normal groups. The gene discussed is ACTA1; the disease is in situ carcinoma.